Ali M S, Sayeski P P, Safavi A, Lyles M, Bernstein K E
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia 30322, USA.
Biochem Biophys Res Commun. 1998 Aug 28;249(3):672-7. doi: 10.1006/bbrc.1998.9054.
Angiotensin II evokes a variety of biological responses by binding to a seven transmembrane cell surface receptor termed AT1. Ligand binding to the AT1 receptor induces the physical association and activation of the intracellular kinase Jak2. To elucidate the mechanism of this association, COS-7 cells were co-transfected with the AT1 receptor and either wild type Jak2 or a catalytically inactive Jak2. AT1 receptor-Jak2 association was assessed in vitro by a GST-AT1 receptor fusion protein binding assay and in vivo by direct co-immunoprecipitation of the receptor-Jak2 complex. Both studies showed that Jak2 must be catalytically active to form a complex with the AT1 receptor, and that complex formation is associated with Jak2 tyrosine phosphorylation. These results were confirmed using the Jak2 specific inhibitor AG-490. We also found that over-expression of wild type Jak2 in COS-7 cells leads to in vivo complex formation of spontaneously autophosphorylated Jak2 with the AT1 receptor. No such complex formation was observed with a dominant negative Jak2. Thus, the physical association of Jak2 with the AT1 receptor is regulated by an angiotensin II mediated autophosphorylation event.
血管紧张素II通过与一种称为AT1的七跨膜细胞表面受体结合,引发多种生物学反应。配体与AT1受体的结合诱导细胞内激酶Jak2的物理缔合和激活。为了阐明这种缔合的机制,将COS-7细胞与AT1受体以及野生型Jak2或催化失活的Jak2共转染。通过GST-AT1受体融合蛋白结合试验在体外评估AT1受体与Jak2的缔合,通过受体-Jak2复合物的直接共免疫沉淀在体内评估。两项研究均表明,Jak2必须具有催化活性才能与AT1受体形成复合物,并且复合物的形成与Jak2酪氨酸磷酸化相关。使用Jak2特异性抑制剂AG-490证实了这些结果。我们还发现,COS-7细胞中野生型Jak2的过表达导致自发自磷酸化的Jak2与AT1受体在体内形成复合物。用显性负性Jak2未观察到这种复合物的形成。因此,Jak2与AT1受体的物理缔合受血管紧张素II介导的自磷酸化事件调节。